- •Foreword
- •Preface
- •Contents
- •Contributors
- •Chapter 1
- •1.1 Introduction
- •1.2 Limitations of Time-Domain OCT
- •1.4 Conclusion
- •References
- •Chapter 2
- •2.1 Background
- •2.3 Clinical Application
- •2.4 Conclusions
- •References
- •Chapter 3
- •Fluorescein Angiography
- •3.1 Principles of Fluorescein Angiography
- •3.2 Procedures for Fluorescein Angiography
- •3.4 Time Course of Fluorescein Angiography
- •3.5 Interpretation of Fluorescein Angiography
- •3.5.1 Hypofluorescent Lesions
- •3.5.2 Hyperfluorescent Lesions
- •3.6 Fluorescein Angiography Today
- •References
- •Chapter 4
- •Wide-Field Imaging and Angiography
- •4.1 Introduction
- •4.2 History of Fundus Imaging
- •4.3.1 Fluorescein Angiography with a Scanning Laser Ophthalmoscope
- •4.3.2 Advantages of Imaging with a Scanning Laser Ophthalmoscope
- •4.4 Clinical Use of Wide-Field Imaging
- •4.4.1 Wide-Field Imaging in Uveitis
- •4.4.4 Wide-Field Imaging of Choroidal Tumors
- •4.5 Future Directions for Fundus Imaging
- •4.6 Conclusion
- •References
- •Chapter 5
- •Autofluorescence Imaging
- •5.1 Introduction
- •5.2 What is Fundus Autofluorescence?
- •5.3 Identification of Early Disease Stages
- •5.4 Phenotyping
- •5.5 Disease Markers
- •5.6 Monitoring of Disease Progression
- •5.7 Disease Mapping
- •5.8 Functional Correlation
- •References
- •Chapter 6
- •Imaging the Macular Pigment
- •6.1 Macular Pigment
- •6.1.1 Characteristics and Potential Functions
- •6.1.3 Spatial Distribution
- •6.1.4 Modifying the Macular Pigment
- •6.1.5 MPOD and Age
- •6.2 Measurement Techniques
- •6.2.1 Heterochromatic Flickerphotometry
- •6.2.2 Fundus reflectance
- •6.2.3 Autofluorescence
- •6.2.4 Raman spectroscopy
- •6.2.5 How do different techniques compare
- •6.3 Imaging
- •6.3.1 Heterochromatic Flickerphotometry
- •6.3.2 Fundus Reflectance
- •6.3.3 Autofluorescence
- •6.3.4 Raman spectroscopy
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Origin of Near-Infrared Autofluorescence
- •7.3 RPE Melanin: Role and Aging
- •7.4 Clinical Cases
- •7.4.1 Age-Related Macular Degeneration
- •7.4.2 Retinal Dystrophies
- •7.4.2.1 Stargardt’s Disease
- •7.4.2.2 Best’s Disease
- •7.4.2.3 Retinitis Pigmentosa
- •7.5 Conclusion
- •References
- •Chapter 8
- •8.1 Introduction
- •8.3.1.1 Classic Choroidal Neovascularization
- •8.3.1.2 Occult Choroidal Neovascularization
- •8.3.1.4 Mixed-Type Choroidal Neovascularization
- •8.3.1.5 Retinal Angiomatous Proliferation
- •8.3.3 Fibrovascular Scar
- •8.5 Conclusions
- •References
- •Chapter 9
- •9.1 Fundus Cameras
- •9.1.1 Standard Images
- •9.1.2 Wide-Angle Images
- •9.1.2.1 Pomerantzeff Equator Plus
- •9.1.2.2 RetCam™
- •RetCam™ Camera Description
- •RetCam™ Technique of Image Capture
- •RetCam™ Problems
- •9.1.2.3 Panoret™
- •9.1.2.4 Optos™
- •9.2.1 Retinal Tumors
- •9.2.1.1 Retinoblastoma
- •9.2.1.2 Astrocytic Hamartoma
- •9.2.1.4 Retinal Cavernous Hemangioma
- •9.2.1.5 Retinal Racemose Hemangioma
- •9.2.1.6 Vasoproliferative Tumor
- •9.2.2 Retinal Pigment Epithelium Tumors
- •9.2.3 Choroidal Tumors
- •9.2.3.1 Choroidal Nevus
- •9.2.3.2 Choroidal Melanoma
- •9.2.4 Anterior Segment Lesions
- •9.2.4.1 Iris Lesions
- •References
- •Chapter 10
- •Metabolic Mapping
- •10.1 Aspects of Metabolism
- •10.4.1 Technical Solution
- •10.5 Clinical Results
- •10.5.1 Age-Related Macular Degeneration
- •10.5.1.1 Detection of Alterations in Early AMD
- •10.5.1.2 Lifetime Images in Late AMD
- •Non-Exudative AMD and Geographic Atrophy
- •Exudative AMD
- •10.5.2.1 Arterial Branch Occlusion
- •10.5.3 Metabolic Alteration in Diabetes Mellitus
- •10.5.3.1 Detection of Fields of Reduced Metabolism
- •References
- •Chapter 11
- •11.1 Diabetic Macular Edema
- •11.2 Examinations in Diabetic Macular Edema
- •11.3 Treatment of Diabetic Macular Edema
- •References
- •Chapter 12
- •12.1.1 Incidence and Natural History
- •12.2 Investigation of Diagnostic Accuracy of OCT for Detection of DME
- •12.2.2 Diagnostic Accuracy of OCT for Detection of DME: Are Photography or Biomicroscopy a Valid Gold Standard?
- •12.2.3 Diagnostic Accuracy of OCT to Detect CSME Using Time-Domain OCTs: How to Use OCT Retinal Thickness Cut-Offs?
- •12.3 Use of OCT When Compared with Photography: Beyond Diagnostic Accuracy
- •12.4 Appendix: Reproducibility of OCT Retinal-Thickness Measurement in Patients with DME
- •12.4.1 How Reproducibility is Reported
- •12.4.3 Spectral-Domain OCTs Reproducibility
- •References
- •Chapter 13
- •13.2 Clinical Features
- •13.3 Examination
- •13.4 Natural History
- •13.5 Ultra-High Resolution OCT and Spectral OCT Findings in Macular Holes
- •13.6 Macular Hole Formation
- •13.7 Postoperative Appearance
- •13.8 Theory of Macular Hole Closure After Vitrectomy
- •13.9 Surgical Considerations
- •13.11 Clinical Features
- •13.12 Treatment
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Vitreous Biochemistry
- •14.3 Vitreo-Retinal Interface Anatomy
- •14.4 Anomalous Posterior Vitreous Detachment (PVD)
- •14.5 Spectral-Domain OCT (SD-OCT)
- •14.6 Vitreo-Maculopathies
- •14.6.1 Macular Pucker (MP)
- •14.6.2 Macular Hole (MH)
- •14.6.2.1 Lamellar Hole (LH)
- •14.6.3 Age-Related Macular Degeneration (AMD)
- •14.6.4 Vitreo-Macular Traction Syndrome (VMTS)
- •14.7 Conclusion
- •References
- •Chapter 15
- •15.3 Imaging the Choroid
- •15.4 Age-Related Choroidal Atrophy
- •15.5 Choroid in High Myopia
- •15.8 Volume Rendering
- •15.9 Summary
- •References
- •Chapter 16
- •16.1 Introduction
- •16.2 Optical Coherence Tomography
- •16.3 Role of Optical Coherence Tomography
- •References
- •Chapter 17
- •17.1 Background and Motivation
- •17.2 Three-Dimensional Imaging of the Choroid
- •17.3 In Vivo Cellular Resolution Retinal Imaging
- •17.4 Polarization Sensitive Retinal OCT
- •17.5 Doppler (Blood Flow) Retinal OCT
- •References
- •Chapter 18
- •Toward Molecular Imaging
- •Summaries for the Clinician
- •References
- •Index
102 |
9 RetCam™ Imaging of Pediatric Intraocular Tumors |
|
|
generally presents in children and young adults. Retinal |
||
|
|
hemangioblastoma can occur as a sporadic tumor or as |
||
|
|
part of von Hippel–Lindau disease, especially if there are |
||
|
|
two or more retinal tumors. Such patients should have |
||
9 |
||||
|
lifelong screening for related brain and visceral tumors. |
|||
|
|
|
|
|
|
|
9.2.1.4 |
Retinal Cavernous Hemangioma |
|
|
|
|
||
|
|
The retinal cavernous hemangioma is a dark red–blue, |
||
|
|
low flow vascular tumor. Occasionally, it can rupture |
||
|
|
and produce vitreous hemorrhage. Some cases are |
||
|
|
associated with the phakomatosis in which there are |
||
|
|
cavernous hemangiomas of the retina, brain, and skin. |
||
|
|
|
|
|
|
|
9.2.1.5 |
Retinal Racemose Hemangioma |
|
|
|
|
||
|
|
Retinal racemose hemangioma is a congenital vascular |
||
|
|
malformation in which some or all of the retinal vessels are |
||
|
|
dilated, often to the point that the arterial system cannot be |
||
|
|
distinguished from the venous system. Visual acuity can be |
||
|
|
normal for extrafoveal tumors and poor for those with |
||
|
|
foveal involvement. This tumor can be associated with the |
||
|
|
Wyburn–Mason syndrome in which similar racemose |
||
|
|
hemangiomas are found in the midbrain, leading to stroke, |
||
|
|
and in the mandible, leading to bleeding at dental work. |
||
|
|
|
|
|
|
|
9.2.1.6 |
Vasoproliferative Tumor |
|
|
|
|
||
|
|
The retinal vasoproliferative tumor is a vascular mass typi- |
||
|
|
cally located in the inferotemporal periphery of the fun- |
||
dus near the ora serrata in middle-aged and older patients [22]. Occasionally, it is found in children. This benign tumor can produce intraretinal and subretinal exudation, subretinal fluid, cystoid macular edema, and epiretinal membrane, leading to poor visual acuity. This tumor is not associated with von Hippel–Lindau disease. This tumor can be idiopathic or related to pars planitis, retinitis pigmentosa, and inflammatory or traumatic conditions.
Summary for the Clinician
■Retinoblastoma is a serious intraocular malignancy in children that can lead to death if there is optic nerve or choroidal invasion.
■Retinal astrocytic hamartoma can appear like retinoblastoma, but the vessels are not dilated and show traction and the calcification is glistening and not chalky.
■Retinal vascular tumors have different clinical features and can be associated with severe systemic consequences.
9.2.2 Retinal Pigment Epithelium Tumors
There are few retinal pigment epithelium (RPE) tumors that can occur in children including congenital hypertrophy of the RPE, congenital simple hamartoma of the RPE, and combined hamartoma of the retina and RPE [18, 19].
9.2.2.1 Congenital Hypertrophy
of the Retinal Pigment Epithelium
Congenital hypertrophy of the RPE (CHRPE) is a flat pigmented lesion arising deep in the retina, typically in the peripheral fundus [23]. It is often discovered coincidentally on ocular examination. CHRPE can display clinical features that resemble choroidal nevus or choroidal melanoma. CHRPE is generally a stable lesion, but can slowly grow over many years.
9.2.2.2 Congenital Simple Hamartoma
of the Retinal Pigment Epithelium
Congenital simple hamartoma of the RPE is a dark black benign tumor located in the macular region, often immediately adjacent to the foveola [24]. It appears like a black ink spot involving full thickness retina. Fine retinal traction can be noted surrounding the mass. Often, there are slightly dilated feeding and draining retinal vessels. This tumor usually remains stable.
9.2.2.3 Combined Hamartoma
of the Retinal Pigment Epithelium
Combined hamartoma of the retinal and RPE is a tractional mass located in the juxtapapillary region more so than the periphery, often associated with poor visual acuity [25, 26]. This gray–green ill-defined mass displays corkscrew, twisted vessels and retinal traction. Optical coherence tomography reveals peaked and folded retina from traction. Rarely, retinal exudation or hemorrh age is found. This lesion can be associated with neurofibromatosis type 2.
Summary for the Clinician
■CHRPE appears as a flat mass often in the periphery and can show slow enlargement over decades.
■Congenital simple hamartoma of the RPE is found in the macula.
■Combine hamartoma of the RPE and retina can produce poor visual acuity if there is macular involvement.
